DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., (“Company” or “Adolore”) announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, ...

Daniel Cressy may now be able to reach his aspirations of becoming a pilot due to medical innovation. Cressy is driving an 18 ...

As transformative as they may be for patients, cell and gene therapies are creating new kinds of uncertainty and challenges ...

At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...

A 9-year-old in South Carolina will become one of only three people in the world to receive an experimental treatment for a ...

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

The scaled adoption of cell and gene therapies demands a new era of agile, precise, and efficient quality control methods.

Outdated manufacturing processes could be obstructing cell and gene therapy advancement.

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...

Gene therapy has been headline news in recent years, in part due to the rapid development of biotechnology that enables doctors to administer such treatments. Broadly, gene therapies are ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping ...